Stem Cell Assays Market to Advance at 16.5% CAGR during 2023 to 2033, TMR Study

Posted on 2024-03-29 by Transparency Market Research in Healthcare // 0 Comments

microscope of cell, Embryonic stem cells, Cellular Therapy and Regeneration 3d illustration.

Wilmington, Delaware, United States, 2024-Mar-29 — /EPR Network/ — Transparency Market Research Inc. –

In 2022, the global lithotripsy device industry boasted a valuation of US$ 1.6 Billion. It is anticipated to experience a robust growth trajectory, with a projected expansion rate of 16.5% from 2023 to 2033. By the culmination of this forecast period, analysts foresee the market scaling up to an impressive valuation of US$ 8.5 Billion.

Among the various segments within the lithotripsy device market, Viability/Cytotoxicity Assays emerge as a significant revenue driver. Projections indicate that this segment will exhibit substantial growth, with a Compound Annual Growth Rate (CAGR) surpassing 16.4% from 2023 to 2033. This underscores the pivotal role of Viability/Cytotoxicity Assays in propelling the overall market forward.

Get Sample PDF: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19364&utm_source=ExpressPress&utm_campaign=MansiR_ExpressPress

What are the Key Drivers Influencing Stem Cell Assays Industry Expansion?

Key drivers fueling market expansion include rising demands for regenerative medicines, advancements in stem cell research technology, increasing prevalence of chronic diseases, and growing investment in research and development.

The expansion of stem cell applications is propelled by the development of innovative stem cell culture techniques such as 3-D cell culture and organoids. This surge in applications necessitates the development of novel stem cell assays to comprehensively comprehend stem cell behavior and characteristics. Stem cells hold promise in regenerative medicine due to their ability to differentiate into various cell types, thereby driving the demand for stem cell-based therapies.

The escalating prevalence of chronic diseases like cancer, diabetes, multiple myeloma, leukemia, Alzheimer’s, and Parkinson’s disease further accentuates the demand for stem cell therapy. Stem cells, with their self-renewable capacity, offer potential solutions for drug discovery, diagnostics, and targeted treatments, contributing to their increasing adoption.

In the United States alone, the burden of diabetes is substantial, with 28.7 million diagnosed cases and 23.6 million reported in 2019. Stem cell therapy presents a promising avenue for diabetes treatment, reflecting the surge in demand for stem cell assays.

Multiple myeloma, a prevalent hematological cancer worldwide, witnessed over 1.6 million new cases in 2018. Stem cell transplant emerges as a potential therapeutic approach for multiple myeloma, thus driving the demand for related treatments and subsequently, stimulating growth in the stem cell assay market.

Competitive Analysis:

Thermo Fischer Scientific, Inc., Merck KGaA, Danaher Corporation, Becton, Dickinson, and Company, Bio-Rad Laboratories, PerkinElmer, Agilent Technologies, Promega Corporation, Cell Biolabs, Bio-Techne Corporation, FUJIFILM Holdings Corporation, Charles River Laboratories, Lonza Group, HemoGenix Inc., and Abcam Plc.

Segmentation of the Stem Cell Assays Market:

By Type:

Viability/Cytotoxicity Assays
- Tetrazolium Reduction Assays
- Resazurium Cell Viability Assay
- Calcein-AM Cell Viability Assay
- Other Viability/Cytotoxicity Assays
Isolation & Purification Assays
Cell Identification Assays
Proliferation Assays
Differentiation Assays
Function Assays
Apoptosis Assays
- Caspase Assays
- Annexin V and Cell Permeability Assays
- DNA Fragmentation Assays
- Mitochondrial Assays

By Cell Type:

Adult Stem Cells
- Mesenchymal Stem Cells
- Induced Pluripotent Stem Cells
- Hematopoietic Stem Cells
- Umbilical Cord Stem Cells
- Neural Stem Cells
Human Embryonic Stem Cells

By Product & Service:

Instruments
- Flow Cytometers
- Microelectrode Arrays
- Cell Imaging & Analysis Systems
- Automated Cell Counters
Kits
Services

By Application:

Regenerative Medicine & Therapy Development
- Orthopedic, Musculoskeletal, and Spine Applications
- Dermatology
- Cardiovascular
- CNS
- Oncology
- Diabetes
- Other Regenerative Medicine & Therapy Development
Drug Discovery and Development
Clinical Research

By End User:

Academic & Research Institutes
Biopharmaceutical & Biotechnology Companies

Market Drivers and Challenges

Drivers:
- Growing investments in stem cell research.
- Rising prevalence of chronic diseases.
- Technological advancements in assay development.
- Supportive government initiatives and funding.
Challenges:
- Ethical concerns associated with stem cell research.
- High cost of stem cell assays and related technologies.
- Complex regulatory landscape.
- Limited awareness and expertise in emerging markets.

Recent Developments:-

In Dec 2021, PPD, Inc., a leading global provider of clinical research services to pharmaceutical and biotech companies acquired by Thermo Fisher Scientific Inc. for US$ 17.4 Billion.
In Oct 2022, JCR Pharmaceuticals Co., Ltd. formed a joint venture with Sysmex Corporation. The objective of this joint venture is the manufacturing of cell-based regenerative medicine products, and to progress its research and development.
In March 2021, Agilent Technologies Inc. announced the acquisition of Resolution Bioscience, a provider of development and commercialization of next-generation sequencing-based precision oncology solutions. In this agreement, Agilent will pay US$ 550 million in cash to Resolution Bioscience Inc., and an additional US$ 145 million on the basis of achieving future performance milestones.

Market Trends

Increasing focus on three-dimensional (3D) cell culture systems.
Integration of artificial intelligence (AI) and machine learning (ML) in stem cell assays.
Rising adoption of microfluidic platforms for high-throughput screening.
Collaboration between academia, industry, and regulatory agencies for standardization and validation of stem cell assays.

Get This Exclusive Report, Instantly: https://www.transparencymarketresearch.com/checkout.php?rep_id=19364&ltype=S&utm_source=ExpressPress&utm_campaign=MansiR_ExpressPress

Regions Covered:

North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)

Future Outlook

The future of the stem cell assays market appears promising, with continued innovations in assay technologies, expanding applications in drug discovery and regenerative medicine, and growing adoption of precision medicine approaches. However, addressing regulatory challenges, enhancing accessibility in emerging markets, and fostering interdisciplinary collaborations will be imperative for sustained growth and advancement in the field.

Key Market Study Points

Comprehensive analysis of market drivers, challenges, and opportunities.
In-depth assessment of regional dynamics and competitive landscape.
Evaluation of emerging trends, technological advancements, and market potential.
Insights into regulatory frameworks, investment trends, and strategic initiatives.

Browse More Reports by TMR:

Helium Market to Reach US$ 3.9 Bn by 2031

Water-free Urinal Market to Gain Value of US$ 207.7 Million by 2031

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Matched content

Editor’s pick